CyPath® Lung
@cypathlung.bsky.social
Noninvasive Early Lung Cancer Detection.
Watch Dr. Michael Nicholson's recent presentation on his use of CyPath® Lung with a free @VuMedi account.
🔗 bit.ly/4qk8txm
Know more. Move forward.
🔗 bit.ly/4qk8txm
Know more. Move forward.
February 5, 2026 at 9:17 PM
Watch Dr. Michael Nicholson's recent presentation on his use of CyPath® Lung with a free @VuMedi account.
🔗 bit.ly/4qk8txm
Know more. Move forward.
🔗 bit.ly/4qk8txm
Know more. Move forward.
Dr Michael Nicholson shares real-world insights on using the noninvasive CyPath® Lung test for #lungcancer in clinical practice. Watch w/ free @VuMedi subscription at bit.ly/4qk8txm
#$BIAF #pulmonology #CyPathLung #earlydetection
#$BIAF #pulmonology #CyPathLung #earlydetection
January 30, 2026 at 9:11 PM
Dr Michael Nicholson shares real-world insights on using the noninvasive CyPath® Lung test for #lungcancer in clinical practice. Watch w/ free @VuMedi subscription at bit.ly/4qk8txm
#$BIAF #pulmonology #CyPathLung #earlydetection
#$BIAF #pulmonology #CyPathLung #earlydetection
When early detection matters, clarity matters, CyPath® Lung gives physicians answers within 72 hours of a viable sample being returned to our lab. Physicians are talking … be a part of the conversation.
January 30, 2026 at 5:52 PM
When early detection matters, clarity matters, CyPath® Lung gives physicians answers within 72 hours of a viable sample being returned to our lab. Physicians are talking … be a part of the conversation.
Lung cancer experts stress the importance of lung cancer screening and value of expanding screening criteria to include more at-risk individuals. See the article in Oncology Live at bit.ly/4k5NBbA and how CyPath® Lung can help at www.cypathlung.com
#lungcancerscreening #CyPathLung #BIAF #lungcancer
#lungcancerscreening #CyPathLung #BIAF #lungcancer
January 27, 2026 at 11:42 PM
Lung cancer experts stress the importance of lung cancer screening and value of expanding screening criteria to include more at-risk individuals. See the article in Oncology Live at bit.ly/4k5NBbA and how CyPath® Lung can help at www.cypathlung.com
#lungcancerscreening #CyPathLung #BIAF #lungcancer
#lungcancerscreening #CyPathLung #BIAF #lungcancer
Dr. Martin Luther King Jr. reminded us that injustice in healthcare is among "the most shocking and inhuman" forms of inequality.
January 19, 2026 at 8:15 PM
Dr. Martin Luther King Jr. reminded us that injustice in healthcare is among "the most shocking and inhuman" forms of inequality.
Only 12% of high-risk Texans receive recommended lung cancer screening — ranking Texas 46th nationally. Early detection and access matter.
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
January 15, 2026 at 6:31 PM
Only 12% of high-risk Texans receive recommended lung cancer screening — ranking Texas 46th nationally. Early detection and access matter.
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
We’re excited to welcome Amy Garcia as a Patient Coach on the CyPath® Lung team! She brings incredible energy, compassion, and dedication to guiding patients through their testing journey, ensuring they feel informed, supported, and confident every step of the way.
January 8, 2026 at 9:03 PM
We’re excited to welcome Amy Garcia as a Patient Coach on the CyPath® Lung team! She brings incredible energy, compassion, and dedication to guiding patients through their testing journey, ensuring they feel informed, supported, and confident every step of the way.
Barry Manilow's recent disclosure of his lung cancer diagnosis underscored a powerful truth: early detection saves lives.
At #CyPathLung, we’re advancing a noninvasive, sputum-based approach to help identify #lungcancer risk as early as Stage 1A.
#earlydetection #BarryManilow
At #CyPathLung, we’re advancing a noninvasive, sputum-based approach to help identify #lungcancer risk as early as Stage 1A.
#earlydetection #BarryManilow
December 22, 2025 at 7:52 PM
Barry Manilow's recent disclosure of his lung cancer diagnosis underscored a powerful truth: early detection saves lives.
At #CyPathLung, we’re advancing a noninvasive, sputum-based approach to help identify #lungcancer risk as early as Stage 1A.
#earlydetection #BarryManilow
At #CyPathLung, we’re advancing a noninvasive, sputum-based approach to help identify #lungcancer risk as early as Stage 1A.
#earlydetection #BarryManilow
Physicians are talking about how CyPath® Lung enables them to intervene early and with confidence…
December 16, 2025 at 10:37 PM
Physicians are talking about how CyPath® Lung enables them to intervene early and with confidence…
CMO Dr. Gordon Downie will present case studies highlighting how CyPath® Lung helped identify Stage 1A at ACS Lung Cancer Roundtable 12.8.2025 from 2:35pm ET.
Read the PR and view the poster here➡️https://bit.ly/3MdSP8i
Read the PR and view the poster here➡️https://bit.ly/3MdSP8i
December 3, 2025 at 6:50 PM
CMO Dr. Gordon Downie will present case studies highlighting how CyPath® Lung helped identify Stage 1A at ACS Lung Cancer Roundtable 12.8.2025 from 2:35pm ET.
Read the PR and view the poster here➡️https://bit.ly/3MdSP8i
Read the PR and view the poster here➡️https://bit.ly/3MdSP8i
See what Dr. Nadarajah had to say about a "typical patient" for CyPath® Lung #physicianhighlight
November 26, 2025 at 4:14 PM
See what Dr. Nadarajah had to say about a "typical patient" for CyPath® Lung #physicianhighlight
Congratulations to Dr. Jairo Rodriguez who was honored by the City of Brownsville for his dedication to early detection and prevention of lung disease. Brownsville city commissioners have proclaimed November 2025 as “Dr. Jairo Rodriguez Appreciation Month.”
November 25, 2025 at 8:43 PM
Congratulations to Dr. Jairo Rodriguez who was honored by the City of Brownsville for his dedication to early detection and prevention of lung disease. Brownsville city commissioners have proclaimed November 2025 as “Dr. Jairo Rodriguez Appreciation Month.”
Where early lung cancer detection meets family-centered care. If you’re at the TAFP Annual Session & Primary Care Summit in Addison, come see our team!
November 14, 2025 at 6:04 PM
Where early lung cancer detection meets family-centered care. If you’re at the TAFP Annual Session & Primary Care Summit in Addison, come see our team!
Strong Q3 for bioAffinity:
• CyPath® Lung volumes ⬆️ 97% YTD
• Record Q3 sales ⬆️ 92% vs. Q2
• Testing revenue ⬆️ 122% YoY
• New U.S. patent
• $10.4M raised
• Back in full Nasdaq compliance
• Two new board members
🔗https://bit.ly/3JDLBcS
• CyPath® Lung volumes ⬆️ 97% YTD
• Record Q3 sales ⬆️ 92% vs. Q2
• Testing revenue ⬆️ 122% YoY
• New U.S. patent
• $10.4M raised
• Back in full Nasdaq compliance
• Two new board members
🔗https://bit.ly/3JDLBcS
November 14, 2025 at 6:03 PM
Strong Q3 for bioAffinity:
• CyPath® Lung volumes ⬆️ 97% YTD
• Record Q3 sales ⬆️ 92% vs. Q2
• Testing revenue ⬆️ 122% YoY
• New U.S. patent
• $10.4M raised
• Back in full Nasdaq compliance
• Two new board members
🔗https://bit.ly/3JDLBcS
• CyPath® Lung volumes ⬆️ 97% YTD
• Record Q3 sales ⬆️ 92% vs. Q2
• Testing revenue ⬆️ 122% YoY
• New U.S. patent
• $10.4M raised
• Back in full Nasdaq compliance
• Two new board members
🔗https://bit.ly/3JDLBcS
bioAffinity Technologies observe #VeteransDay by reaffirming our commitment to helping Veterans live longer and healthier lives through early detection of lung cancer. CyPath® Lung is now available to Veterans through the VA health system.
November 11, 2025 at 6:41 PM
bioAffinity Technologies observe #VeteransDay by reaffirming our commitment to helping Veterans live longer and healthier lives through early detection of lung cancer. CyPath® Lung is now available to Veterans through the VA health system.
November is #LungCancerAwarenessMonth.
Lung cancer is the leading cause of cancer death worldwide, and anyone with lungs can be at risk.
Awareness and early detection save lives, we're proud to advance science and education that help make that possible.
Lung cancer is the leading cause of cancer death worldwide, and anyone with lungs can be at risk.
Awareness and early detection save lives, we're proud to advance science and education that help make that possible.
November 6, 2025 at 11:20 PM
November is #LungCancerAwarenessMonth.
Lung cancer is the leading cause of cancer death worldwide, and anyone with lungs can be at risk.
Awareness and early detection save lives, we're proud to advance science and education that help make that possible.
Lung cancer is the leading cause of cancer death worldwide, and anyone with lungs can be at risk.
Awareness and early detection save lives, we're proud to advance science and education that help make that possible.
This #LungCancerAwarenessMonth, bioAffinity Tech ($BIAF) reports accelerating growth in sales of CyPath® Lung, with October test volume up 111% over 2025’s average.
Early detection saves lives. Learn more: bit.ly/4qL5v6h
Early detection saves lives. Learn more: bit.ly/4qL5v6h
November 5, 2025 at 11:02 PM
This #LungCancerAwarenessMonth, bioAffinity Tech ($BIAF) reports accelerating growth in sales of CyPath® Lung, with October test volume up 111% over 2025’s average.
Early detection saves lives. Learn more: bit.ly/4qL5v6h
Early detection saves lives. Learn more: bit.ly/4qL5v6h
Day 2 at #CHEST2025! Great conversations with clinicians & researchers advancing noninvasive lung diagnostics.
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
October 21, 2025 at 8:54 PM
Day 2 at #CHEST2025! Great conversations with clinicians & researchers advancing noninvasive lung diagnostics.
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
Big week at #CHEST2025!
Dr. Rossella Titone shares new research showing how CyPath® Lung stays accurate from sample to result. Proud of Dr. Titone, Dr. Downie & Dr. Elzi for representing!
Dr. Rossella Titone shares new research showing how CyPath® Lung stays accurate from sample to result. Proud of Dr. Titone, Dr. Downie & Dr. Elzi for representing!
October 20, 2025 at 8:11 PM
Big week at #CHEST2025!
Dr. Rossella Titone shares new research showing how CyPath® Lung stays accurate from sample to result. Proud of Dr. Titone, Dr. Downie & Dr. Elzi for representing!
Dr. Rossella Titone shares new research showing how CyPath® Lung stays accurate from sample to result. Proud of Dr. Titone, Dr. Downie & Dr. Elzi for representing!
October 20, 2025 at 3:34 PM
AI is revolutionizing cancer detection. The USPTO plans to grant bioAffinity Technologies a patent for our AI-powered flow cytometry platform that detects lung cancer with precision and consistency. Learn more: bit.ly/42N8CAq
#CyPathLung #cancerdiagnostics #patent #AI
#CyPathLung #cancerdiagnostics #patent #AI
bit.ly
October 17, 2025 at 3:24 PM
AI is revolutionizing cancer detection. The USPTO plans to grant bioAffinity Technologies a patent for our AI-powered flow cytometry platform that detects lung cancer with precision and consistency. Learn more: bit.ly/42N8CAq
#CyPathLung #cancerdiagnostics #patent #AI
#CyPathLung #cancerdiagnostics #patent #AI
Reposted by CyPath® Lung
The ATS and CAPC are proud to introduce a new collaborative series of seven modules on ATS Ed+ for clinicians treating patients with serious illnesses. Earn CME! #pallipulm @anandiyermd.bsky.social @donsullivan.bsky.social @pallipulm.bsky.social
Learn more: atsedplus.thoracic.org/capc/palliat...
Learn more: atsedplus.thoracic.org/capc/palliat...
September 30, 2025 at 4:30 PM
The ATS and CAPC are proud to introduce a new collaborative series of seven modules on ATS Ed+ for clinicians treating patients with serious illnesses. Earn CME! #pallipulm @anandiyermd.bsky.social @donsullivan.bsky.social @pallipulm.bsky.social
Learn more: atsedplus.thoracic.org/capc/palliat...
Learn more: atsedplus.thoracic.org/capc/palliat...
On World Lung Day, we honor patients and families and look forward with hope. CyPath® Lung is committed to earlier detection, so every patient can have more time and more moments.
#WorldLungDay #LungHealth #EarlyDetection #CyPathLung
#WorldLungDay #LungHealth #EarlyDetection #CyPathLung
September 25, 2025 at 8:02 PM
On World Lung Day, we honor patients and families and look forward with hope. CyPath® Lung is committed to earlier detection, so every patient can have more time and more moments.
#WorldLungDay #LungHealth #EarlyDetection #CyPathLung
#WorldLungDay #LungHealth #EarlyDetection #CyPathLung
Indeterminate lung nodules don’t have to mean uncertainty.
CyPath® Lung is a noninvasive sputum test that uses flow cytometry to deliver:
✅92% sensitivity
✅87% specificity
Fewer unnecessary procedures.
Clearer, faster answers.
#LungCancer #EarlyDetection #CyPathLung
CyPath® Lung is a noninvasive sputum test that uses flow cytometry to deliver:
✅92% sensitivity
✅87% specificity
Fewer unnecessary procedures.
Clearer, faster answers.
#LungCancer #EarlyDetection #CyPathLung
September 23, 2025 at 8:33 PM
Indeterminate lung nodules don’t have to mean uncertainty.
CyPath® Lung is a noninvasive sputum test that uses flow cytometry to deliver:
✅92% sensitivity
✅87% specificity
Fewer unnecessary procedures.
Clearer, faster answers.
#LungCancer #EarlyDetection #CyPathLung
CyPath® Lung is a noninvasive sputum test that uses flow cytometry to deliver:
✅92% sensitivity
✅87% specificity
Fewer unnecessary procedures.
Clearer, faster answers.
#LungCancer #EarlyDetection #CyPathLung
CyPath® Lung helped detect a malignancy in ground-glass nodules in a 66-year-old patient with a smoking history, supporting earlier detection and better care.
Watch Dr. Guda’s interview: www.cypathlung.com
#LungCancer #EarlyDetection #CyPathLung #PhysicainHighlights
Watch Dr. Guda’s interview: www.cypathlung.com
#LungCancer #EarlyDetection #CyPathLung #PhysicainHighlights
September 11, 2025 at 3:07 PM
CyPath® Lung helped detect a malignancy in ground-glass nodules in a 66-year-old patient with a smoking history, supporting earlier detection and better care.
Watch Dr. Guda’s interview: www.cypathlung.com
#LungCancer #EarlyDetection #CyPathLung #PhysicainHighlights
Watch Dr. Guda’s interview: www.cypathlung.com
#LungCancer #EarlyDetection #CyPathLung #PhysicainHighlights